本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Lexeo Therapeutics

9.35
+0.26002.86%
盤後9.350.00000.00%17:55 EST
成交量:92.07萬
成交額:855.39萬
市值:6.82億
市盈率:-3.81
高:9.45
開:9.16
低:9.11
收:9.09
52周最高:10.38
52周最低:1.45
股本:7,298.73萬
流通股本:4,500.50萬
量比:0.80
換手率:2.05%
股息:- -
股息率:- -
每股收益(TTM):-2.4545
每股收益(LYR):-3.0934
淨資產收益率:-80.69%
總資產收益率:-44.66%
市淨率:5.65
市盈率(LYR):-3.02

資料載入中...

2025/02/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/19

重要事件披露

Form 8-K - Current report
2024/12/17

SEC問詢函

Form CORRESP - Correspondence
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/12

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/30

重要事件披露

Form 8-K - Current report
2024/10/09

重要事件披露

Form 8-K - Current report
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/08/09

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]